Loading…
Loading…
Structured register of government actions in the geoeconomic space — export controls, tariffs, sanctions, FDI screening, subsidies, industrial-policy laws — cross-referenced into the country, minerals, and ETF surface. Charter: docs/IPTM_CHARTER.md.
Severity 1-5 is the qualitative impact rating (1=minor, 5=structural). The bilateral-trade-grounded quant scorer is the next IPTM milestone. RBI (Register Breadth Index) is a complementary structural-breadth indicator from scripts/py/iptm/breadth.py; divergence between RBI and severity is itself informative (high-sev / low-RBI = strategic chokepoint; low-sev / high-RBI = broad but shallow). Every action has at least one primary source URL. Verify-or-don't-file. See also themes, timeline, graph, sankey, map, country exposure, sector exposure, material exposure (+ graph), weekly briefs, portfolio scan, escalation monitor, trans-shipment hubs. Internal triage tools (RSS-poller candidate feed, source-feed health) live under /admin/candidates + /admin/sources. Subscribe via Atom feed (accepts ?country=CN, ?material=lithium, ?issuer=BIS, ?type=export_control, ?etf=SOXX, ?company=NVDA, ?minSeverity=4, ?year=2026, ?q=…) or pull /api/iptm/actions.
On 4 January 2023 the Union Cabinet of India, chaired by Prime Minister Narendra Modi, approved the National Green Hydrogen Mission with an initial financial outlay of ₹19,744 crore (≈USD 2.3 bn) covering FY2023-24 through FY2029-30. The bulk of the outlay — ₹17,490 crore — funds the Strategic Interventions for Green Hydrogen Transition (SIGHT) programme for electrolyser-manufacturing incentives and green-hydrogen production incentives. ₹1,466 crore is allocated to pilot projects (steel, mobility, shipping, ports, decentralised hydrogen), ₹400 crore to R&D, and ₹388 crore to other Mission components (skilling, regulatory framework, certification). The Ministry of New and Renewable Energy (MNRE) is the lead implementing agency. Headline targets by 2030: at least 5 MMT/year of domestic green-hydrogen production capacity, with ≈125 GW of associated additional renewable- energy capacity, mobilisation of >₹8 lakh crore (≈USD 100 bn) of total investment, creation of >600,000 jobs, and avoidance of ≈50 MMT/year of CO₂ emissions. The Mission is positioned as the supply-chain underpinning for India's hard-to-abate decarbonisation (refining, fertilisers, steel) and as the basis for a green-hydrogen export industry leveraging India's low-cost solar resource. MNRE notified the SIGHT scheme guidelines on 28 June 2023, splitting the programme into Component I (Electrolyser Manufacturing Incentive, ₹4,440 crore) and Component II (Green Hydrogen Production Incentive, ₹13,050 crore for Mode-1; subsequent Mode-2A and Mode-2B tranches added for sector-specific tenders). Solar Energy Corporation of India (SECI) is the implementing agency for both components and runs the competitive reverse-auction tenders.
The Department of Pharmaceuticals notified the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) on 21 July 2020 via Gazette Notification, with an outlay of Rs 6,940 crore (~USD 920m) over FY 2020-21 to FY 2027-28. The scheme covers 41 identified critical bulk-drug products across four target segments — fermentation-based (Key Fermentation; Niche Fermentation) and chemical synthesis-based (Key Chemical Synthesis; Niche Chemical Synthesis) — paying 20% incentive on incremental sales for fermentation-based products (years 1-4) tapering to 15% (year 5) and 5% (year 6), and a flat 20% over 5 years for chemically-synthesised products. The stated objective is to reduce India's ~70% bulk-drug import dependence on China by establishing greenfield domestic manufacturing capacity with at least 90% domestic value addition for fermentation products and 70% for chemical-synthesis products.